Litcius/Paper detail

Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.<i>Fas</i><sup>lpr</sup> mice

Hong Kyung Lee, Hyung Sook Kim, Minji Pyo, Eun Jae Park, Sundong Jang, Hye Won Jun, Tae Yong Lee, Kyung Suk Kim, Sang‐Cheol Bae, Youngsoo Kim, Jin Tae Hong, Jaesuk Yun, Sang‐Bae Han

2020Theranostics26 citationsDOIOpen Access PDF

Abstract

Taken together, our data demonstrate that phorbol esters might be good tool compounds to activate MSCs to inhibit B cells and suggest that our chemical approach might allow for improvements in the therapeutic efficacy of hMSCs in SLE.

Topics & Concepts

Mesenchymal stem cellStem cellChemistryCancer researchSystemic lupus erythematosusMolecular biologyCell biologyImmunologyPharmacologyMedicineBiologyPathologyDiseaseMesenchymal stem cell researchMicroRNA in disease regulationOsteoarthritis Treatment and Mechanisms
Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.<i>Fas</i><sup>lpr</sup> mice | Litcius